Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Recursion Pharmaceuticals Inc (RXRX) – Recursion Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

RXRX trades at $3.45, down 1.71% with mixed technical signals showing a bullish overall trend but bearish moving averages. The company reported revenue of $74M in 2025 but sustained a significant net loss of $645M, resulting in negative profit margins. Recent earnings showed beats in Q3 and Q4 2025, while analyst sentiment is divided with 40% buy ratings and a consensus price target of $7.00, representing over 100% upside potential from current levels.
The stock presents high-risk, high-reward potential with strong analyst upside targets but faces substantial execution risks given negative profitability and high cash burn. Investors should weigh the promising AI-driven drug discovery platform against the company's current financial challenges and the inherent volatility of clinical-stage biotech investments.
Read full analysis

Key Stats

  • Market Cap
    $1.84B
  • Sector
    Health
  • 3M Drawdown
    -34.26%
  • Enterprise Value
    $1.17B
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    14 days
$3.43
52W Low: $2.84
30 Mar 2026
52W High: $6.79
15 Oct 2025

Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.84B, with an enterprise value of $1.17B. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -34.26%, reflecting recent price volatility. On average, investors hold Recursion Pharmaceuticals Inc for approximately 14 days, indicating typical investor behavior on the platform.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.


Technical Indicators
|
|
|
Overall Summary
Bearish (17)Neutral (2)Bullish (8)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.84B
  • Sector
    Health
  • 3M Drawdown
    -34.26%
  • Enterprise Value
    $1.17B
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    14 days
$3.43
52W Low: $2.84
30 Mar 2026
52W High: $6.79
15 Oct 2025

Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.84B, with an enterprise value of $1.17B. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -34.26%, reflecting recent price volatility. On average, investors hold Recursion Pharmaceuticals Inc for approximately 14 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!